vs
Side-by-side financial comparison of Information Services Group Inc. (III) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $61.2M, roughly 1.5× Information Services Group Inc.). Vericel Corp runs the higher net margin — 25.0% vs 4.3%, a 20.7% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 5.9%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $4.3M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -2.4%).
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
III vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.2M | $92.9M |
| Net Profit | $2.6M | $23.2M |
| Gross Margin | 44.8% | 78.7% |
| Operating Margin | 8.4% | 24.1% |
| Net Margin | 4.3% | 25.0% |
| Revenue YoY | 5.9% | 23.3% |
| Net Profit YoY | -14.1% | 17.3% |
| EPS (diluted) | $0.06 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.2M | $92.9M | ||
| Q3 25 | $62.4M | $67.5M | ||
| Q2 25 | $61.6M | $63.2M | ||
| Q1 25 | $59.6M | $52.6M | ||
| Q4 24 | $57.8M | $75.4M | ||
| Q3 24 | $61.3M | $57.9M | ||
| Q2 24 | $64.3M | $52.7M | ||
| Q1 24 | $64.3M | $51.3M |
| Q4 25 | $2.6M | $23.2M | ||
| Q3 25 | $3.1M | $5.1M | ||
| Q2 25 | $2.2M | $-553.0K | ||
| Q1 25 | $1.5M | $-11.2M | ||
| Q4 24 | $3.0M | $19.8M | ||
| Q3 24 | $1.1M | $-901.0K | ||
| Q2 24 | $2.0M | $-4.7M | ||
| Q1 24 | $-3.4M | $-3.9M |
| Q4 25 | 44.8% | 78.7% | ||
| Q3 25 | 42.2% | 73.5% | ||
| Q2 25 | 42.2% | 73.7% | ||
| Q1 25 | 43.1% | 69.0% | ||
| Q4 24 | 41.5% | 77.6% | ||
| Q3 24 | 40.4% | 71.9% | ||
| Q2 24 | 39.5% | 69.5% | ||
| Q1 24 | 36.1% | 68.9% |
| Q4 25 | 8.4% | 24.1% | ||
| Q3 25 | 7.4% | 5.1% | ||
| Q2 25 | 7.6% | -3.2% | ||
| Q1 25 | 5.7% | -24.3% | ||
| Q4 24 | 0.3% | 24.5% | ||
| Q3 24 | 7.0% | -4.3% | ||
| Q2 24 | 5.7% | -11.5% | ||
| Q1 24 | -3.7% | -10.7% |
| Q4 25 | 4.3% | 25.0% | ||
| Q3 25 | 4.9% | 7.5% | ||
| Q2 25 | 3.5% | -0.9% | ||
| Q1 25 | 2.5% | -21.4% | ||
| Q4 24 | 5.3% | 26.3% | ||
| Q3 24 | 1.9% | -1.6% | ||
| Q2 24 | 3.2% | -8.9% | ||
| Q1 24 | -5.3% | -7.5% |
| Q4 25 | $0.06 | $0.46 | ||
| Q3 25 | $0.06 | $0.10 | ||
| Q2 25 | $0.04 | $-0.01 | ||
| Q1 25 | $0.03 | $-0.23 | ||
| Q4 24 | $0.07 | $0.40 | ||
| Q3 24 | $0.02 | $-0.02 | ||
| Q2 24 | $0.04 | $-0.10 | ||
| Q1 24 | $-0.07 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.7M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $94.7M | $354.6M |
| Total Assets | $211.0M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.7M | $137.5M | ||
| Q3 25 | $28.7M | $135.4M | ||
| Q2 25 | $25.2M | $116.9M | ||
| Q1 25 | $20.1M | $112.9M | ||
| Q4 24 | $23.1M | $116.2M | ||
| Q3 24 | $9.7M | $101.7M | ||
| Q2 24 | $11.8M | $102.5M | ||
| Q1 24 | $14.0M | $110.6M |
| Q4 25 | $94.7M | $354.6M | ||
| Q3 25 | $94.7M | $321.9M | ||
| Q2 25 | $94.1M | $306.8M | ||
| Q1 25 | $95.0M | $295.5M | ||
| Q4 24 | $96.3M | $292.0M | ||
| Q3 24 | $96.6M | $257.5M | ||
| Q2 24 | $95.5M | $243.0M | ||
| Q1 24 | $95.6M | $233.9M |
| Q4 25 | $211.0M | $488.0M | ||
| Q3 25 | $213.3M | $453.3M | ||
| Q2 25 | $200.7M | $435.6M | ||
| Q1 25 | $202.4M | $424.6M | ||
| Q4 24 | $204.5M | $432.7M | ||
| Q3 24 | $227.1M | $390.4M | ||
| Q2 24 | $235.3M | $376.8M | ||
| Q1 24 | $234.2M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.1M | $15.0M |
| Free Cash FlowOCF − Capex | $4.3M | $12.8M |
| FCF MarginFCF / Revenue | 7.0% | 13.8% |
| Capex IntensityCapex / Revenue | 1.2% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.94× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $25.0M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $15.0M | ||
| Q3 25 | $11.1M | $22.1M | ||
| Q2 25 | $11.9M | $8.2M | ||
| Q1 25 | $978.0K | $6.6M | ||
| Q4 24 | $6.6M | $22.2M | ||
| Q3 24 | $8.8M | $10.2M | ||
| Q2 24 | $2.2M | $18.5M | ||
| Q1 24 | $2.3M | $7.2M |
| Q4 25 | $4.3M | $12.8M | ||
| Q3 25 | $9.5M | $19.5M | ||
| Q2 25 | $11.1M | $81.0K | ||
| Q1 25 | $141.0K | $-7.6M | ||
| Q4 24 | $6.0M | $8.5M | ||
| Q3 24 | $8.4M | $-9.2M | ||
| Q2 24 | $1.3M | $1.8M | ||
| Q1 24 | $1.3M | $-6.8M |
| Q4 25 | 7.0% | 13.8% | ||
| Q3 25 | 15.2% | 28.8% | ||
| Q2 25 | 18.0% | 0.1% | ||
| Q1 25 | 0.2% | -14.5% | ||
| Q4 24 | 10.4% | 11.2% | ||
| Q3 24 | 13.7% | -15.9% | ||
| Q2 24 | 2.0% | 3.4% | ||
| Q1 24 | 2.0% | -13.3% |
| Q4 25 | 1.2% | 2.4% | ||
| Q3 25 | 2.5% | 3.9% | ||
| Q2 25 | 1.4% | 12.9% | ||
| Q1 25 | 1.4% | 27.0% | ||
| Q4 24 | 0.9% | 18.3% | ||
| Q3 24 | 0.6% | 33.5% | ||
| Q2 24 | 1.4% | 31.8% | ||
| Q1 24 | 1.6% | 27.3% |
| Q4 25 | 1.94× | 0.65× | ||
| Q3 25 | 3.62× | 4.35× | ||
| Q2 25 | 5.46× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 2.15× | 1.12× | ||
| Q3 24 | 7.66× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
III
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
